Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients.
June Young ChunKichun KimMin Kyeong LeeChang Kyung KangYoungil KohDong-Yeop ShinJunshik HongPyoeng Gyun ChoeNam Joong KimSung-Soo YoonPyoeng Gyun ChoeInho KimMyoung-Don OhPublished in: BMC infectious diseases (2021)
Our findings demonstrate that a live HZ vaccine is immunogenic and safe when administered 2 years post-HSCT.
Keyphrases